This dual role in coordinating tumor metabolism and immunomodulation has propelled PYCR1 into the forefront of translational oncology research, though mechanistic details of its tumorigenic circuitry and therapeutic vulnerability remain to be fully deciphered [18,19]. Here, PYCR1 is linked to neoplasm.